cyclosporine has been researched along with Communicable Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (75.86) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YK; Choi, BS; Chung, BH; Hong, YA; Hwang, HS; Kim, SY; Kim, Y; Kim, YS; Park, CW; Yang, CW; Yoon, HE | 1 |
| Bañares, R; Carbone, J; Clemente, G; Fernandez-Cruz, E; Jensen, J; Micheloud, D; Rincon, D; Rodriguez-Molina, J; Salcedo, M; Sarmiento, E | 1 |
| Gatt, ME; Kedmi, M; Levy, L; Nasereddin, A; Rav-Acha, M; Rund, D | 1 |
| Balduzzi, A; Cesaro, S; Dini, G; Favre, C; Lanino, E; Locatelli, F; Messina, C; Pession, A; Pollichieni, S; Rabusin, M; Rondelli, R; Santarone, S | 1 |
| Guo, Z; He, X; Kong, Y; Liang, W; Ling, X; Shang, Y; Wang, D | 1 |
| White, DA | 1 |
| Bandini, AM; Billes, A; Blanc, AS; Boissonnat, P; Dorent, R; Epailly, E; Gandjbakhch, I; Guillemain, R; Lelong, B; Lemay, D; Mattei, MF; Pol, A; Redonnet, M; Treilhaud, M; Vermes, E | 1 |
| Ascher, NL; Goldstein, R; Gonwa, T; Klintmalm, GB; Krom, RA; Lake, J; Roberts, JW; Shaw, BW; Stratta, R; Wiesner, RH | 1 |
| Brekke, B; Ekberg, H; Tydén, G; Wadström, J; Wramner, L | 1 |
| Carmellini, M; Di Stefano, R; Mosca, F; Oleggini, M; Pietrabissa, A; Rindi, P; Rizzo, G; Romagnoli, J | 1 |
| Bailey, L; Fagoaga, O; Grinde, S; Nehlsen-Cannarella, S; Thorpe, R; Wahlstrom, E | 1 |
| Dienemann, H; Forst, H; Hammer, C; Kreuzer, E; Kur, F; Meiser, BM; Reichart, B; Reichenspurner, H; Rihl, M; Wagner, F | 1 |
| Griffin, PJ; Johnson, RW; Kohlhaw, K; Land, W; Moore, R; Pichlmayr, R; Salaman, JR; Sells, R | 1 |
| Duff, J; Ghent, C; Grant, D; McAlister, V; Roy, A; Wall, W; Zhong, R | 1 |
| Demetris, AJ; Griffith, BP; Hattler, BG; Kawai, A; Kormos, RL; Murali, S; Pham, SM | 1 |
| Belitsky, P; Boucher, A; Cole, E; Daloze, P; Dandavino, R; Halloran, P; Handa, P; Hendricks, L; Jeffrey, J; Keown, P; Landsberg, D; Lawen, J; Loertscher, R; Muirhead, N; Parfrey, P; Paul, L; Rush, D; Russell, D; Shoker, A; Stiller, C; Tan, A; Zaltzman, J | 1 |
| al-Abdullah, IH; Cahill, K; Kumar, AM; Kumar, MS; Laskow, DA; Panigrahi, D; Seirka, D; Singleton, R | 1 |
| Artemiou, O; Birsan, T; Dekan, G; Klepetko, W; Kupilik, N; Thaghavi, S; Wolner, E; Zuckermann, A | 1 |
| Chapman, W; Geevarghese, S; Helderman, JH; MacDonell, R; Payne, J; Pinson, CW; Richie, R; Van Buren, D; Wright, JK | 1 |
| Cheung, A; Menkis, AH | 1 |
| Albrecht, KH; Heemann, U; Kohnle, M; Spillner, J | 1 |
| Hu, RH; Lee, CJ; Lee, PH; Tsai, MK | 1 |
| Fischer, A; Goy, JJ; Hurni, M; Mueller, X; Ruchat, P; Seydoux, C; Stumpe, F; von Segesser, L | 1 |
| Kokot, F; Nowicki, M; Ritz, E; Wiecek, A | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Angelico, M; Casciani, CU; Di Paolo, D; Orlando, G; Palmieri, GP; Strati, F; Tisone, G | 1 |
| Donadi, MO; Esmeraldo, RM; Oliveira, ML; Pinheiro, PM; Ponte, CN | 1 |
| Becker, GJ; Jamil, B; Nicholls, K; Walker, RG | 1 |
| Butt, KM; Davis, R; Delaney, V; Dibenedetto, A; Hong, JH; Sumrani, N | 1 |
4 review(s) available for cyclosporine and Communicable Diseases
| Article | Year |
|---|---|
Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.
Topics: Calcineurin; Calcineurin Inhibitors; Communicable Diseases; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Incidence; Kidney; Kidney Function Tests; Liver Transplantation; Male; Randomized Controlled Trials as Topic; Survival Analysis; Tacrolimus; Time Factors | 2011 |
Drug-induced pulmonary infection.
Topics: Aspergillosis; Communicable Diseases; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases; Methotrexate; Pneumonia, Pneumocystis; Purine Nucleosides; Tacrolimus; Tuberculosis; Tumor Necrosis Factor-alpha | 2004 |
Cyclosporine heart transplantation.
Topics: Communicable Diseases; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Postoperative Complications; Survival Rate | 1998 |
Acute failure of the transplanted kidney--pathophysiology, diagnosis and prevention.
Topics: Acute Disease; Animals; Communicable Diseases; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Postoperative Complications; Treatment Failure | 1996 |
12 trial(s) available for cyclosporine and Communicable Diseases
| Article | Year |
|---|---|
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Topics: Adolescent; Child; Child, Preschool; Communicable Diseases; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Postoperative Complications; Prospective Studies; Recurrence; Transplantation, Homologous | 2009 |
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Endpoint Determination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recombinant Fusion Proteins; Risk Factors; Steroids; Transplantation Immunology; Treatment Outcome | 2007 |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Topics: Acute Disease; Acute Kidney Injury; Adrenal Cortex Hormones; Bilirubin; Chronic Disease; Communicable Diseases; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Liver Function Tests; Liver Transplantation; Male; Muromonab-CD3; Renal Dialysis; Survival Analysis; Tacrolimus; Time Factors | 1993 |
Triple versus quadruple induction immunosuppression in pancreas transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Pancreas Transplantation; Postoperative Complications; Prednisolone; Reoperation | 1995 |
Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy.
Topics: Adult; Communicable Diseases; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 1993 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Muromonab-CD3; Prednisone; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous | 1996 |
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.
Topics: Administration, Oral; Adult; Blood Pressure; Canada; Communicable Diseases; Cyclosporine; Emulsions; Female; Follow-Up Studies; Humans; Kidney Transplantation; Living Donors; Male; Middle Aged; Neoplasms; Postoperative Complications; Prospective Studies; Time Factors; Tissue Donors | 1998 |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; CD3 Complex; Child; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Postoperative Complications; Prospective Studies; Survival Rate; T-Lymphocyte Subsets; Tacrolimus | 1998 |
Mycophenolate mofetil in lung transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Respiratory Tract Infections; Survival Rate | 1998 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Function Tests; Liver Transplantation; Methylprednisolone Hemisuccinate; Postoperative Complications; Regression Analysis; Retrospective Studies; Tacrolimus | 1998 |
Anti-LFA-1 monoclonal antibody in renal transplantation: renal function, infections, and other complications.
Topics: Antibodies, Monoclonal; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Function-Associated Antigen-1; Postoperative Complications; Prednisone; Urinary Tract Infections | 1998 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
13 other study(ies) available for cyclosporine and Communicable Diseases
| Article | Year |
|---|---|
Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Communicable Diseases; Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Remission Induction; Renal Replacement Therapy; Retrospective Studies; Risk Assessment; Risk Factors; Seoul; Time Factors; Treatment Outcome | 2019 |
Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibody Formation; Biomarkers; Communicable Diseases; Complement C3; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunity, Cellular; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Lymphocyte Count; Male; Middle Aged; Monitoring, Immunologic; Postoperative Complications; Prednisone; Prognosis; Prospective Studies; Risk Factors; Spain; Survival Analysis; T-Lymphocytes; Tacrolimus | 2008 |
Prolonged fever, hepatosplenomegaly, and pancytopenia in a 46-year-old woman.
Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Communicable Diseases; Cyclosporine; Diagnosis, Differential; Female; Fever; Hepatomegaly; Humans; Immunosuppressive Agents; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Lymphohistiocytosis, Hemophagocytic; Macrophages; Middle Aged; Neoplasms; Opportunistic Infections; Pancytopenia; Polymerase Chain Reaction; Splenomegaly | 2009 |
Evaluation of infections in renal transplant recipients treated with cyclosporine.
Topics: Antilymphocyte Serum; Communicable Diseases; Cyclosporine; Follow-Up Studies; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lung Diseases; Muromonab-CD3; Retrospective Studies; Time Factors | 1994 |
Evaluation of predictors of rejection and infection in cyclosporine-treated solid organ transplant recipients.
Topics: Antigens, CD; Communicable Diseases; Cyclosporine; Discriminant Analysis; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Monitoring, Physiologic; Predictive Value of Tests; Prognosis; Receptors, Interleukin-2; Retrospective Studies; Time Factors; Transplantation Immunology; Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1994 |
Pulmonary rejection diagnosis after lung and heart-lung transplantation.
Topics: Azathioprine; Communicable Diseases; Cyclosporine; Diagnosis, Differential; Graft Rejection; Heart-Lung Transplantation; Humans; Lung Diseases; Lung Transplantation; Methylprednisolone; Postoperative Complications; Respiratory Function Tests; Retrospective Studies | 1993 |
Immunosuppressive requirements for small bowel/liver transplantation.
Topics: Antilymphocyte Serum; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Duodenum; Humans; Immunosuppression Therapy; Intestine, Small; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Pancreas Transplantation; Postoperative Complications; Prednisone; Stomach; Transplantation, Homologous | 1993 |
Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
Topics: Azathioprine; Cause of Death; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Morbidity; Postoperative Complications; Prednisolone; Retrospective Studies; Survival Rate; Taiwan | 1998 |
Effects of cyclosporine A monotherapy on the incidence of rejection and infection episodes in heart transplant patients.
Topics: Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Time Factors | 1998 |
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids.
Topics: Adult; Azathioprine; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulin M; Immunosuppressive Agents; Kidney Function Tests; Leukocyte Count; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Steroids | 1999 |
Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Communicable Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Postoperative Complications; Risk Factors | 1999 |
Impact of acute rejection therapy on infections and malignancies in renal transplant recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Communicable Diseases; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Neoplasms; Postoperative Complications; Retrospective Studies; Risk; Risk Factors; Survival Analysis; Time Factors | 1999 |
Causes of late renal allograft failure in the ciclosporin era.
Topics: Adult; Communicable Diseases; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Male; Patient Compliance; Time Factors | 1992 |